Ontario becomes the first province to list fluvoxamine as a COVID-19 treatment to consider
Ontario has become the first province to list an inexpensive and well-known antidepressant as a treatment doctors can “consider” for patients with a mild COVID-19 infection in a bid to keep them out of hospital.
In the science table listing on Wednesday, a panel indicated that the drug fluvoxamine can be considered and prescribed to patients with a mild case who are at risk of having more severe symptoms.
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) antidepressant that is typically used to treat depression and obsessive-compulsive disorders.
“Right now, we're in a really unprecedented wave of Omicron and we have just a staggering number of patients getting infected,” Dr. Menaka Pai, associate professor of medicine at McMaster University and co-chair of the Ontario COVID-19 Science Advisory Table, told CTV News. “Our goal is to keep them safe, to keep them out of hospital and also to preserve our scarcest resource, which I would say is our hospital beds.”
The drug costs a little more than a dollar a day and would be taken for 15 days, starting with a small dose. In comparison, the antivirals medicines from Pfizer and Merck cost nearly $1,000 dollars per patient.
Studies have shown that the drug can cut hospital admissions due to COVID-19 by up to 30 per cent.
“When you look at all that data together, it is very likely that fluvoxamine prevents hospitalization in patients with mild COVID-19,” Pai said. “So patients who are not yet on oxygen, and if our goal in this wave of the pandemic is to stop patients with COVID from ending up in those scarce hospital beds, then that I think is a very important finding, indeed.”
Researchers at McMaster University monitored more than 1,500 unvaccinated COVID-19-positive patients for a month and gave them either the drug or a placebo.
Of those who received fluvoxamine, 10.6 per cent required treatment by a doctor for more than six hours or were hospitalized, while 15.7 per cent of the participants who received a placebo were hospitalized or needed physician treatment for more than six hours. When patients took all of their drugs, the noted beneficial effect went up to 65 per cent, the study found.
Dr. Edward Mills, the co-principal investigator of the trial, said the results could be a game-changer, particularly in developing countries with low vaccination rates.
“It’s a very large treatment effect, one that hasn’t been observed for any drug yet,” he told CTV News back in October when the study was published.
John’s Hopkins University has also endorsed the drug for use within seven days of symptoms, provided the patient is not in their third trimester of pregnancy.
While Ontario is the first province to list the drug as an option, Pai said other regions are also considering the medication as a possible preventative therapy.
CTVNews.ca Top Stories

4 in custody after 'brutal' death of Quebec entrepreneur, partner in Dominica
Four people are in police custody after Quebec businessman Daniel Langlois and his partner Dominique Marchand were found dead in Dominica.
Speaker Fergus apologizes, faces calls to resign over 'personal' video played at Ontario Liberal event
House of Commons Speaker Greg Fergus apologized to MPs on Monday about a 'personal' video tribute message played this weekend at the Ontario Liberal Party leadership convention, but two opposition parties say that's not enough and are now calling for him to resign over his 'unacceptable' participation in a partisan event.
Unanimous vote to install menorah and nativity scene at Moncton City Hall
In a unanimous vote Monday night, Moncton City Council passed a motion to immediately install the menorah and nativity scene outside of city hall.
Canada's grocery retail sector one of the most competitive on Earth: Sobeys CEO
The top executive at Sobeys asserted on Monday that Canada has one of the most competitive grocery retail sectors on the planet -- even as Canadians continue to feel the bite of higher prices.
opinion As Trump burns through cash, powerful Republicans are rallying behind a surging candidate
With less than 50 days until Republican voters begin the process of determining their nominee to take on President Joe Biden, political analyst Eric Ham writes about a storm brewing within the GOP -- as super-donors align behind a surging candidate who could pose a threat to frontrunner Donald Trump.
Escaped kangaroo found safe after 3 days on the loose in Ontario
A kangaroo that escaped the Oshawa Zoo during a one-night stay last week has been recaptured after more than three days on the loose.
George Santos is offering personalized videos for US$200
George Santos already has a new gig. The former congressman, fresh off his historic expulsion last week, has created a Cameo account where the public can pay for a personalized video message.
70-year-old Ugandan woman gives birth to twins after fertility treatment
A 70-year-old woman in Uganda has given birth to twins after receiving fertility treatment, making her one of the world's oldest new mothers.
CBC says it is cutting 600 jobs, some programming as it slashes budget
The Canadian Broadcasting Corp. and Radio-Canada will eliminate about 600 jobs and not fill an additional 200 vacancies. The cuts at CBC come days after the Liberal government suggested it may cap the amount of money CBC and Radio-Canada could get under a $100 million deal Ottawa recently signed with Google.